Abstract

BackgroundIn the last years, high throughput genotyping techniques have widely used for the characterization of new genetic variants associated with rheumatic diseases. Amongst these, Illumina Beadchip microarrays have been widely...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
EnsembleCNV: an ensemble machine learning algorithm to identify and genotype copy number variation using SNP array data.
Zhongyang Zhang ... Johan L M Bjorkegren
Nucleic acids research | VOL. 47
Zhongyang Zhang, et. al.Zhongyang Zhang ... Johan L M Bjorkegren
05 Feb 2019
The Role of Copy Number Variation in Susceptibility to Amyotrophic Lateral Sclerosis: Genome-Wide Association Study and Comparison with Published Loci
Louise V Wain ... Ulrich Mueller
PloS one | VOL. 4
Louise V Wain, et. al.Louise V Wain ... Ulrich Mueller
04 Dec 2009
Accurate Detection of Clinically Actionable Copy Number Variants in Diverse Hematological Neoplasms By Routine Targeted Sequencing: A Comparative Performance Study
Alicia Palomino Mosquera ... Ash A Alizadeh
Blood | VOL. 140
Alicia Palomino Mosquera, et. al.Alicia Palomino Mosquera ... Ash A Alizadeh
15 Nov 2022
Using family data as a verification standard to evaluate copy number variation calling strategies for genetic association studies.
Xiaojing Zheng ... Caitlin P Mchugh
Genetic epidemiology | VOL. 36
Xiaojing Zheng, et. al.Xiaojing Zheng ... Caitlin P Mchugh
01 Apr 2012
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
The associations between poorer pain-related health status and increased hospitalisations and excess mortality in patients with rheumatoid arthritis (RA): a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD)
Huai Leng Pisaniello ... Samuel Lawrance Whittle
Annals of the Rheumatic Diseases | VOL. -
Huai Leng Pisaniello, et. al.Huai Leng Pisaniello ... Samuel Lawrance Whittle
29 May 2024
Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years
Gerd R Burmester ... Daniel Aletaha
Annals of the Rheumatic Diseases | VOL. -
Gerd R Burmester, et. al.Gerd R Burmester ... Daniel Aletaha
23 May 2024
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
Weijia Wang ... Yong Yuan
Annals of the Rheumatic Diseases | VOL. -
Weijia Wang, et. al.Weijia Wang ... Yong Yuan
22 May 2024
Exploring the effect on primary endpoints in trials testing targeted therapy interventions for rheumatoid arthritis: a meta-epidemiological study on the appropriate use of a core outcome set
Philip Rask Lage-Hansen ... Robin Christensen
Annals of the Rheumatic Diseases | VOL. -
Philip Rask Lage-Hansen, et. al.Philip Rask Lage-Hansen ... Robin Christensen
22 May 2024
View more papers